Dynamic view of the MS genome

In the first ever sequencing of twin genomes, researchers searched deep into the genetics of multiple sclerosis, coupling DNA sequencing with a panoramic look at the regulation and expression of genes, only to come up empty-handed. "It's really a tour de force," said linkurl:Eric Topol,;http://www.scripps.edu/research/faculty.php?rec_id=23654 director of the Scripps Translational Science Institute, who was not involved in the research. "It's a fascinating study. It's sobering that they didn't f

Written byMegan Scudellari
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
In the first ever sequencing of twin genomes, researchers searched deep into the genetics of multiple sclerosis, coupling DNA sequencing with a panoramic look at the regulation and expression of genes, only to come up empty-handed. "It's really a tour de force," said linkurl:Eric Topol,;http://www.scripps.edu/research/faculty.php?rec_id=23654 director of the Scripps Translational Science Institute, who was not involved in the research. "It's a fascinating study. It's sobering that they didn't find obvious [genetic factors]."
Identical twins
Image: National Institute of
General Medical Sciences
The study, published this week in Nature, included three pairs of identical twins, two female pairs and one male, in which one had multiple sclerosis (MS) and the other did not. No one knows the cause of MS. Some evidence points to a genetic root of the neurodegenerative disorder: In thirty percent of identical twins where one has MS, so does the other. Changes to the human leukocyte antigen (HLA) region of chromosome 6 has been linked to an increased susceptibility to MS, and 6 genome-wide association studies implicate 12 other loci in the disease. However, strong evidence also suggests environmental risk factors for MS: In the majority of identical twin cases, only one has MS, and epidemiological studies have suggested month of birth and decreased sunlight exposure can increase risk of developing MS. "It's one of those complicated diseases where there are both genetic effects and environmental effects," said linkurl:Stephen Kingsmore,;http://www.ncgr.org/staff/bios#sfk senior author on the study and CEO of the linkurl:National Center for Genome Resources;http://www.ncgr.org/ in Santa Fe, New Mexico. In order to systematically dissect the effects of genetics versus environment in MS, Kingsmore and collaborators, including researchers at the Multiple Sclerosis Genetics Research Laboratory at the University of California, San Francisco, first sequenced the genomes of CD4+ lymphocytes -- cells believed to attack brain tissue and strip myelin from neurons in patients with MS. They sequenced the entire genome of one pair of female identical twins, one of whom had MS, and confirmed that they indeed had identical genomes. "Then we started to look under more rocks," said Kingsmore. Adding an additional two pairs of discordant twins to the study, the team moved onto the epigenome, analyzing the methylation of each twin's genome, genetic modifications that alter gene expression. They found no differences there either. Finally, the team looked at the expressed genome, the transcriptome, for any significant differences in levels of gene expression. There were none. "For everything we did, we tried to use several different technologies to validate our findings," said Kingsmore, including assessing variation in single nucleotide polymorphisms, copy number variations, and HLA sequences. In the end, with three levels of genomic analysis, the team found no significant genetic, epigenetic, or transcriptome differences between individuals with MS and those without. "There was nothing obvious, which is amazing considering how much effort they put in," said Topol. This type of panoramic view of the genome, or pan-omics, as Topol calls it, is a comprehensive method that will likely be used to study other complex diseases. The results, or lack thereof, point to a strong environmental trigger for MS, said Kingsmore, yet neither he nor others are ready to rule out a genetic component. "It's a problem of missing heritability," said Topol. "There's lots more to be done before we wave our hands," he added. For example, the researchers only looked at the genomes of T cells, believed to be the aggressors in MS but not the only possible players. Kingsmore hopes to repeat the analysis with brain tissue, where the actual demyelination of neurons occurs. "It is possible the [cause] is in the brain, just being recognized by the CD4 lymphocytes," said Kingsmore. "It's a missing piece before we can definitively say we looked at twins and there are no differences." "Obviously this would be an easier sell if we'd found something," added Kingsmore, "But we did rule out a lot of things." S.E. Baranzini et al., "Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis," Nature 464(29):1351-6, 2010.
**__Related stories:__***linkurl:Twins Diverge;http://www.the-scientist.com/article/display/53128/
[1st May 2007]*linkurl:A New Approach to Autoimmune Diseases;http://www.the-scientist.com/article/display/13751/
[5th May 2003]*linkurl:Double jeopardy in multiple sclerosis;http://www.the-scientist.com/article/display/20648/
[3rd September 2002]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform